BMY Earnings

Quarterly EPS
$0.60
Q3 2024
$0.04
Q4 2024
$1.21
Q1 2025
$0.64
Q2 2025
$1.08
Q3 2025
$0.53
Q4 2025
$1.31
Q1 2026
$1.62
Q2 2026
Latest Revenue13.0B
Latest Net Income3.3B
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.6213.0B3.3B+5.7%+153.1%
Q1 2026$1.3111.5B2.7B+2.6%+8.3%
Q4 2025$0.5312.5B1.1B+1.3%+1,225.0%
Q3 2025$1.0812.2B2.2B+2.8%+80.0%
Q2 2025$0.6412.3B1.3B+0.6%-22.9%
Q1 2025$1.2111.2B2.5B-5.6%+120.5%
Q4 2024$0.0412.3B76.0M+7.5%-95.4%
Q3 2024$0.6011.9B1.2B+8.4%-36.2%
Q2 2024$0.8312.2B1.7B
Q1 2024-$5.8911.9B-11908000000
Q4 2023$0.8711.5B1.8B
Q3 2023$0.9411.0B1.9B
Bristol-Myers Squibb (BMY) — Earnings